查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1716808

微针药物输送系统市场（按产品、材料、应用和最终用户划分）—2025-2030 年全球预测

Microneedle Drug Delivery Systems Market by Product, Material, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

微针药物输送系统市值在 2024 年为 53.5 亿美元，预计在 2025 年将达到 57.4 亿美元，预计到 2030 年将以 7.60% 的复合年增长率增长至 83.1 亿美元。

主要市场统计数据
基准年2024年 53.5亿美元
预计2025年 57.4亿美元
预测年份 2030 83.1亿美元
复合年增长率（%） 7.60%

微针药物输送系统是治疗领域的一项突破性进步，为传统方法提供了一种微创且高效的替代方法。这种创新方法体现了数十年的研究和不断改进，结合科学和工程来克服与针头给药相关的挑战。此技术利用微小的针头穿透皮肤表层，从而实现精确且可控的药物输送。除了提高患者的舒适度之外，这项创新还有可能彻底改变各种治疗方法，特别是在快速吸收至关重要的领域。材料科学、生物医学工程和药物配方的融合推动了这项技术的成熟。随着全球医疗保健的进步，微针设备正在成为治疗慢性和急性疾病、降低风险和改善整体疗效的重要工具。

随着对高效、低剂量、安全治疗方案的需求不断增长，微针技术的出现脱颖而出。它能够提供缓释性释放特性、提高生物利用度和微创性，代表着在各种疾病条件下治疗方法的变革性变化。随着持续的研究和技术改进，微针系统将重塑世界各地的患者照护通讯协定。

改变微针药物输送系统市场

近年来，创新的微针技术大幅改变了药物输送格局。这一转变的特征是策略性地从传统的皮下注射转向更以患者为中心的、强调效率和精确的治疗方法。随着微型化和製造技术的进步，微针系统正在迅速发展，融合了尖端材料和新颖的设计结构。提高患者的依从性、增强药物吸收、降低感染风险，支持从传统方法朝向更现代、更具适应性的技术的演变。

创新研究和开发不断进步，从而产生了更强大的设备，可提供从疫苗输送到慢性病管理等多方面的应用。这种转变源自于对皮肤生理学的深刻理解和对个人化医疗的承诺。目前的重点是开发不仅高效且可扩展且具有成本效益的系统，以便在不同的治疗领域中广泛的应用。由此带来的潜在益处包括降低住院率、提高生活品质和整体减少全身副作用，为业界树立了新的标竿。

细分洞察揭示详细的市场动态

详细的細項分析为了解微针药物输送系统不断变化的市场动态提供了关键见解。该研究根据产品类型、材料配置、应用和最终用户类别对市场进行考察。在产品细分方面，市场分为可溶解微针、中空微针、水凝胶形成微针和固态微针。这样的分类可以帮助相关人员了解各种微针设计在机制和性能上的细微差别。

从材料细分来看，这些设备由陶瓷、金属和聚合物组成。例如，陶瓷包括氧化铝和氧化锆，金属包括不銹钢和钛。在聚合物中，聚乳酸-乙醇酸共聚物、聚乳酸和聚乙烯吡咯烷酮等材料在生产过程占主导地位，每种材料在生物相容性和劣化特性方面都具有独特的优势。市场区隔透过探索微针系统在癌症治疗、皮肤病学、疼痛管理和疫苗传递的应用进一步细分市场。此外，最终用户细分揭示了门诊手术中心、诊断实验室、家庭医疗保健机构、医院和诊所以及生命科学和研究实验室的趋势。总之，这些见解提供了对市场结构的详细了解，以指南产品开发和策略性业务决策。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 对无痛、微创给药方法的需求不断增加，以提高患者依从性
      • 越来越多地采用自我管理技术减少了对医疗保健专业人员的依赖
    • 限制因素
      • 高昂的研发成本限制了先进微针技术的商业化
    • 机会
      • 微加工和微针设计的进步推动了药物输送创新
      • 加大研发投入将加速新型药物传输解决方案的开发
    • 任务
      • 严格的监管核准流程和广泛的临床试验要求阻碍了其应用
  • 市场区隔分析
    • 产品：中空微针由于其精确的剂量控制和快速起效的特性，在疫苗传输领域迅速获得应用
    • 材质：PLGA 微针因其多功能性而在精准药物释放应用中广受欢迎。
    • 应用：扩大微针药物传输在皮肤病学和疼痛管理的应用
    • 最终用户：速度、效率和可靠性正在推动医院和诊所对微针系统的需求激增。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章微针药物输送系统市场（依产品）

  • 溶解微针
  • 中空微针
  • 水凝胶成型微针
  • 实心微针

第七章微针药物输送系统市场（依材料）

  • 陶瓷
    • 氧化铝
    • 氧化锆
  • 金属
    • 不銹钢
    • 钛
  • 聚合物
    • 聚乳酸-乙醇酸
    • 聚乳酸
    • 聚乙烯吡咯烷酮

第八章微针药物传输系统市场应用

  • 癌症治疗
  • 皮肤科
  • 疼痛管理
  • 疫苗递送

第九章微针药物输送系统市场（按最终用户划分）

  • 门诊手术中心
  • 诊断实验室
  • 家庭医疗保健
  • 医院和诊所
  • 生命科学与研究实验室

10. 美洲微针药物输送系统市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第11章亚太微针药物传输系统市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

12. 欧洲、中东和非洲微针药物输送系统市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • AbbVie Inc.
  • AdminMed nanoBioSciences LLC
  • Aesthetics Biomedical, Inc.
  • Anodyne Nanotech, Inc.
  • ASTI Corporation
  • Becton, Dickinson and Company
  • Biolinq Incorporated
  • CeraVx
  • CosMED Pharmaceutical Co., Ltd.
  • Delpor, Inc.
  • DermapenWorld by Equipmed USA LLC
  • FUJIFILM Holdings Corporation
  • Gylden Pharma Limited
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson Services Inc.
  • Kindeva Drug Delivery LP
  • LTS Lohmann Therapie-Systeme AG
  • Medrx Co., Ltd.
  • Medtronic PLC
  • Microdermics
  • Micron Biomedical, Inc.
  • Micropoint Technologies Pte Ltd
  • NanoPass Technologies Ltd.
  • PharmaTher Holdings Ltd.
  • QuadMedicine
  • Raphas Co., Ltd.
  • SeriTech
  • Sorrento Therapeutics, Inc.
  • TheraJect, Inc.
  • Valeritas Inc
  • Vaxess Technologies, Inc.
  • Vaxxas
  • Verndari, Inc.
  • Vetter
Product Code: MRR-563BF1FCECD0

The Microneedle Drug Delivery Systems Market was valued at USD 5.35 billion in 2024 and is projected to grow to USD 5.74 billion in 2025, with a CAGR of 7.60%, reaching USD 8.31 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 5.35 billion
Estimated Year [2025] USD 5.74 billion
Forecast Year [2030] USD 8.31 billion
CAGR (%) 7.60%

Microneedle drug delivery systems represent a groundbreaking advancement in the field of therapeutics, offering a minimally invasive and highly efficient alternative to traditional methods. This innovative approach encapsulates decades of research and continuous improvement, merging science and engineering to overcome challenges associated with needle-based administration. The technology leverages microscopic needles that penetrate the skin's upper layers, enabling precise and controlled drug delivery. This innovation not only enhances patient comfort but also has the potential to revolutionize how various treatments are administered, especially in areas where rapid absorption is critical. The maturation of this technology has been driven by convergence between material science, biomedical engineering, and pharmaceutical formulation. As the global healthcare landscape evolves, microneedle devices are emerging as a vital tool in addressing both chronic and acute medical conditions while reducing risks and improving overall outcomes.

In the context of increasing demand for efficient, low-dosage, and safer treatment options, the advent of microneedle technology stands out. Its capacity to offer sustained-release profiles, improved bioavailability, and minimal invasiveness marks a transformative shift in how therapies are delivered across a spectrum of disease states. With ongoing research and technology refinement, microneedle systems are poised to reshape patient care protocols around the world.

Transformative Shifts in the Therapeutic Delivery Landscape

Recent years have witnessed transformative shifts in the landscape of drug delivery, driven largely by innovative microneedle technology. These shifts are characterized by a strategic move from conventional hypodermic injections to more patient-centric treatment modalities that emphasize efficiency and precision. Advances in miniaturization and manufacturing methodologies have allowed microneedle systems to evolve rapidly, incorporating state-of-the-art materials and novel design architectures. The improved patient compliance, enhanced drug absorption, and reduced risk of infection underscore the evolution from traditional methods to more modern and adaptable techniques.

Innovative research and development continuously forge ahead, creating more robust devices that offer multifaceted applications ranging from vaccine delivery to chronic disease management. This transformation is enhanced by a deeper understanding of skin physiology and a commitment to personalized medicine. The focus is now squarely on developing systems that are not only efficient but also scalable and cost-effective, ensuring a broad reach across different therapeutic areas. Consequently, the potential benefits include decreased hospitalization rates, improved quality of life, and an overall reduction in systemic side effects, thereby setting new industry benchmarks.

Segmentation Insights: Unlocking Detailed Market Dynamics

An in-depth segmentation analysis provides critical insight into the evolving market dynamics of microneedle drug delivery systems. The study examines the market based on product type, material composition, application, and end-user category. In terms of product segmentation, the market is assessed across dissolving microneedles, hollow microneedles, hydrogel-forming microneedles, and solid microneedles. Such categorization assists stakeholders in understanding the nuanced differences in mechanism and performance among various microneedle designs.

Looking at material-based segmentation, the devices are constructed from ceramics, metal, and polymer. Ceramics, for example, focuses on alumina and zirconia, while metals include options such as stainless steel and titanium. Among polymers, materials like poly lactic-co-glycolic acid, polylactic acid, and polyvinylpyrrolidone dominate the production process, each conferring unique benefits in terms of biocompatibility and degradation profiles. The application segmentation further refines the market by exploring the use of microneedle systems in cancer therapy, dermatology, pain management, and vaccine delivery. Additionally, end-user segmentation elucidates trends among ambulatory surgical centers, diagnostic laboratories, home healthcare environments, hospitals and clinics, as well as life science and research laboratories. Collectively, these insights help construct a detailed picture of the market's structure, guiding both product development and strategic business decisions.

Based on Product, market is studied across Dissolving Microneedles, Hollow Microneedles, Hydrogel-forming Microneedles, and Solid Microneedles.

Based on Material, market is studied across Ceramics, Metal, and Polymer. The Ceramics is further studied across Alumina and Zirconia. The Metal is further studied across Stainless Steel and Titanium. The Polymer is further studied across Poly Lactic-co-Glycolic Acid, Polylactic Acid, and Polyvinylpyrrolidone.

Based on Application, market is studied across Cancer Therapy, Dermatology, Pain Management, and Vaccine Delivery.

Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Laboratories, Home Healthcare, Hospitals & Clinics, and Life Science & Research Laboratories.

Regional Insights: A Global Perspective on Market Penetration

The geographic distribution of microneedle drug delivery systems reveals significant regional trends that underpin market growth. In the Americas, robust healthcare infrastructure and a fast-paced adoption of cutting-edge technologies are key drivers behind market expansion. The region demonstrates strong regulatory support and a high rate of clinical trials, setting the tone for the integration of microneedle technologies into mainstream healthcare practices.

Across Europe, the Middle East & Africa, there is an increasing emphasis on innovative therapeutic methods to address diverse public health challenges. Regulatory frameworks in these regions are evolving to accommodate novel technological offerings, ensuring that advancements in microneedle delivery are effectively and safely integrated into medical protocols. Meanwhile, the Asia-Pacific region is witnessing swift market growth spurred by rising healthcare expenditures, improving access to advanced treatment modalities, and a heightened awareness of patient-centric solutions. Together, these regions form a mosaic of dynamic markets that are increasingly converging on the common goal of revolutionizing traditional therapeutic practices through microneedle innovations.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Competitive Landscape: Deep Dive into Leading Innovators

The competitive landscape of the microneedle drug delivery market is marked by a diverse array of companies that are actively driving technology refinement and market adoption. Key industry players such as AbbVie Inc., AdminMed nanoBioSciences LLC, Aesthetics Biomedical, Inc., and Anodyne Nanotech, Inc. are spearheading initiatives to optimize the design and usability of microneedle systems. Other influential companies include ASTI Corporation, Becton, Dickinson and Company, Biolinq Incorporated, and CeraVx, among many others. These organizations are at the forefront of research and development, propelling continuous improvements in microneedle technology.

In addition, companies such as CosMED Pharmaceutical Co., Ltd., Delpor, Inc., DermapenWorld by Equipmed USA LLC, and FUJIFILM Holdings Corporation are leveraging their considerable expertise to further integrate microneedle systems into diverse therapeutic applications. Collaborative efforts and strategic partnerships are typical in this space, as seen with the involvement of Gylden Pharma Limited, Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson Services Inc., and Kindeva Drug Delivery L.P. The competitive environment is further enriched by firms like LTS Lohmann Therapie-Systeme AG, Medrx Co., Ltd., Medtronic PLC, and Microdermics, which are expanding the boundaries of what can be achieved through advanced drug delivery systems. Leading innovators such as Micron Biomedical, Inc., Micropoint Technologies Pte Ltd, NanoPass Technologies Ltd., PharmaTher Holdings Ltd., QuadMedicine, and others continue to demonstrate their commitment to enhancing patient outcomes through meticulous research and development. This robust competitive framework not only fosters a culture of innovation but also accelerates the transition of cutting-edge research into commercial applications, thereby setting new standards for therapeutic precision and efficacy.

The report delves into recent significant developments in the Microneedle Drug Delivery Systems Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AdminMed nanoBioSciences LLC, Aesthetics Biomedical, Inc., Anodyne Nanotech, Inc., ASTI Corporation, Becton, Dickinson and Company, Biolinq Incorporated, CeraVx, CosMED Pharmaceutical Co., Ltd., Delpor, Inc., DermapenWorld by Equipmed USA LLC, FUJIFILM Holdings Corporation, Gylden Pharma Limited, Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson Services Inc., Kindeva Drug Delivery L.P., LTS Lohmann Therapie-Systeme AG, Medrx Co., Ltd., Medtronic PLC, Microdermics, Micron Biomedical, Inc., Micropoint Technologies Pte Ltd, NanoPass Technologies Ltd., PharmaTher Holdings Ltd., QuadMedicine, Raphas Co., Ltd., SeriTech, Sorrento Therapeutics, Inc., TheraJect, Inc., Valeritas Inc, Vaxess Technologies, Inc., Vaxxas, Verndari, Inc., and Vetter. Strategic Recommendations: Empowering Future Market Leaders

Industry leaders are encouraged to strategically invest in research and development while fostering collaborations across interdisciplinary fields to drive innovation in microneedle technology. Considering the rapid evolution in material sciences and biomedical engineering, it is crucial to integrate advanced polymers and metals that offer improved biocompatibility and mechanical strength. Companies should explore opportunities to diversify their product portfolios by incorporating both dissolving and hydrogel-forming microneedle configurations, thereby addressing a wider spectrum of clinical needs.

Moreover, it is advisable to cultivate strong partnerships with research institutes and clinical laboratories to accelerate the translational process from bench to bedside. By leveraging data analytics and real-world evidence, organizations can tailor their product development strategies to meet evolving market demands. Regulatory preparedness is another important facet: proactively engaging with regulatory bodies to streamline approval processes can significantly reduce time-to-market. Finally, targeted investments in emerging markets-especially within dynamic regions that are rapidly adopting advanced medical technologies-will help capture a larger share of the global market. These strategic measures will enable industry leaders to not only stay ahead of the curve but also to set new benchmarks in the realm of therapeutic innovation.

Conclusion: Embracing the Future of Drug Delivery

In summary, the evolution of microneedle drug delivery systems marks a pivotal moment in the transformation of therapeutic administration. The trajectory of this technology is defined by its unparalleled ability to integrate state-of-the-art material science with precise engineering, transforming the way medications are delivered. By offering improved patient comfort, enhanced bioavailability, and the capacity to target a multitude of clinical applications, microneedle systems are reshaping the future of drug delivery.

The significance of this evolution is not confined to technological breakthroughs alone; it extends to the broader implications for public health and global medical practices. With meticulous segmentation analyses and insight into regional as well as company-specific trends, the narrative of microneedle technology underscores its potential to revolutionize both patient care and industry standards. As we embrace a future where precision and personalization are paramount, microneedle technology stands as a testament to the power of innovation in addressing pressing healthcare challenges.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for painless and minimally invasive drug delivery methods enhancing patient compliance
      • 5.1.1.2. Increasing adoption of self-administration techniques reducing reliance on healthcare professionals
    • 5.1.2. Restraints
      • 5.1.2.1. High research and development costs limiting the commercialization of advanced microneedle technology
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in microfabrication and microneedle design driving innovation in drug delivery
      • 5.1.3.2. Growing investment in research and development accelerating novel drug delivery solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory approval processes and extensive clinical trial requirements hindering adoption
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Significant adoption of hollow microneedles in vaccine administration due to their precise dosage control and rapid onset of action
    • 5.2.2. Material: High preference for PLGA microneedles in precise drug release applications owing to their versatility
    • 5.2.3. Application: Expanding usage of microneedle drug delivery in dermatology and pain management
    • 5.2.4. End-User: Proliferating demand for microneedle systems in hospitals & clinics due to their speed, efficiency, and reliability
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Microneedle Drug Delivery Systems Market, by Product

  • 6.1. Introduction
  • 6.2. Dissolving Microneedles
  • 6.3. Hollow Microneedles
  • 6.4. Hydrogel-forming Microneedles
  • 6.5. Solid Microneedles

7. Microneedle Drug Delivery Systems Market, by Material

  • 7.1. Introduction
  • 7.2. Ceramics
    • 7.2.1. Alumina
    • 7.2.2. Zirconia
  • 7.3. Metal
    • 7.3.1. Stainless Steel
    • 7.3.2. Titanium
  • 7.4. Polymer
    • 7.4.1. Poly Lactic-co-Glycolic Acid
    • 7.4.2. Polylactic Acid
    • 7.4.3. Polyvinylpyrrolidone

8. Microneedle Drug Delivery Systems Market, by Application

  • 8.1. Introduction
  • 8.2. Cancer Therapy
  • 8.3. Dermatology
  • 8.4. Pain Management
  • 8.5. Vaccine Delivery

9. Microneedle Drug Delivery Systems Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Diagnostic Laboratories
  • 9.4. Home Healthcare
  • 9.5. Hospitals & Clinics
  • 9.6. Life Science & Research Laboratories

10. Americas Microneedle Drug Delivery Systems Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Microneedle Drug Delivery Systems Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Microneedle Drug Delivery Systems Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Kindeva Drug Delivery and Emervax partner to bring vaccine administration to patients
    • 13.3.2. LTS and partners secure BARDA Patch Forward funding to advance dissolvable microneedle mRNA vaccine delivery systems
    • 13.3.3. uPATCH secures INZET fund to enhance microneedle drug delivery technology
    • 13.3.4. Thanh Nguyen's innovative microneedle patch advances multivalent vaccine delivery
    • 13.3.5. Daewoong pharmaceutical unveils microneedle patch and once-monthly semaglutide injection
    • 13.3.6. CD Formulation unveils innovative hydrogel microneedle patch technology enhancing drug absorption and loading capacity for better health outcomes
    • 13.3.7. Sandia collaboration enhances microneedle drug delivery technology
    • 13.3.8. Sorrento Therapeutics secures a U.S. patent for an innovative microneedle drug delivery device
    • 13.3.9. University of North Carolina introduced wireless-controlled 'smart band-aid' patches
    • 13.3.10. LTS transforming mRNA vaccine delivery in low- and middle-income countries with support from the Gates Foundation
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. Kindeva Drug Delivery L.P.
    • 13.4.2. DermapenWorld by Equipmed USA LLC
    • 13.4.3. Biolinq Incorporated

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. AdminMed nanoBioSciences LLC
  • 3. Aesthetics Biomedical, Inc.
  • 4. Anodyne Nanotech, Inc.
  • 5. ASTI Corporation
  • 6. Becton, Dickinson and Company
  • 7. Biolinq Incorporated
  • 8. CeraVx
  • 9. CosMED Pharmaceutical Co., Ltd.
  • 10. Delpor, Inc.
  • 11. DermapenWorld by Equipmed USA LLC
  • 12. FUJIFILM Holdings Corporation
  • 13. Gylden Pharma Limited
  • 14. Hisamitsu Pharmaceutical Co., Inc.
  • 15. Johnson & Johnson Services Inc.
  • 16. Kindeva Drug Delivery L.P.
  • 17. LTS Lohmann Therapie-Systeme AG
  • 18. Medrx Co., Ltd.
  • 19. Medtronic PLC
  • 20. Microdermics
  • 21. Micron Biomedical, Inc.
  • 22. Micropoint Technologies Pte Ltd
  • 23. NanoPass Technologies Ltd.
  • 24. PharmaTher Holdings Ltd.
  • 25. QuadMedicine
  • 26. Raphas Co., Ltd.
  • 27. SeriTech
  • 28. Sorrento Therapeutics, Inc.
  • 29. TheraJect, Inc.
  • 30. Valeritas Inc
  • 31. Vaxess Technologies, Inc.
  • 32. Vaxxas
  • 33. Verndari, Inc.
  • 34. Vetter

LIST OF FIGURES

  • FIGURE 1. MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET MULTI-CURRENCY
  • FIGURE 2. MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET MULTI-LANGUAGE
  • FIGURE 3. MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 4. MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET DYNAMICS
  • TABLE 7. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISSOLVING MICRONEEDLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOLLOW MICRONEEDLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY HYDROGEL-FORMING MICRONEEDLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY SOLID MICRONEEDLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY ALUMINA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY ZIRCONIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY TITANIUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLY LACTIC-CO-GLYCOLIC ACID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYVINYLPYRROLIDONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CANCER THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY VACCINE DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIFE SCIENCE & RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY CERAMICS, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY METAL, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUC